Shetzline Michael 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Shetzline Michael
SVP, CMO, Head-Res&Drug
Transactions
- Award
Class A Common Stock
2024-01-17+57,971→ 379,102 total
Footnotes (1)
- [F1]Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 26, 2021. The earned PSUs were certified and vested on January 17, 2024.